Article thumbnail

The follow-up of patients of sixty-five years of age and younger with acute ischemic stroke and transient ischemic attacks, and elevated D-dimer levels in plasma

By Magnus Vrethem and Tomas Lindahl

Abstract

D-dimer levels in plasma, a degradation product of fibrin, have been shown to correlate with the severity of ischemic stroke. In order to investigate the outcome of patients with elevated D-dimer we have carried out a follow-up study of patients of 65 years of age and younger with acute ischemic stroke or transient ischemic attacks (TIA) admitted to our stroke unit from 1991 to 1992. Twenty-two of the 57 patients had elevated D-dimer levels in the plasma. High levels were associated with cardioembolic stroke. On follow-up after a mean of 12 years, 15 patients had died and six patients had suffered another stroke or TIA (three of whom were dead). Ten patients had suffered other cardiovascular events and seven of them were dead. We concluded that high levels of D-dimer in acute ischemic stroke patients on admission were associated with cardioembolic stroke and might have prognostic value for the development of further cardioor cerebrovascular events. Advanced age was found to be an independent risk factor

Topics: Article
Publisher: PAGEPress Publications
OAI identifier: oai:pubmedcentral.nih.gov:3093219
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1991). Activation of coagulation in acute cardioembolic stroke.
  2. Alterations of haemostatic markers in various subtypes and phases of stroke.
  3. (1990). Antiphospholipid antibodies and cerebral ischemia in young people.
  4. Association between deficiency of free protein S and anticardiolipin antibodies in patients ≤65 years of age with acute ischemic stroke and TIA.
  5. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke.
  6. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
  7. (2005). D-dimer testing in ischemic stroke and cerebral sinus and venous thrombosis. Semin Vasc Med
  8. Ddimer is not a long-term prognostic marker following acute cerebral ischemia.
  9. Ddimer predicts early clinical progression in ischemic stroke: confirmation using routine clinical assays.
  10. Fibrin D-dimer and cardiovascular risk.
  11. (1990). Hematologic disorders and ischemic stroke: A selective review.
  12. Hemostatic activation in acute ischemic stroke.
  13. Hemostatic markers in acute stroke.
  14. (1995). High levels of anticardiolipin antibodies is an unusual finding in an unselected stroke population.
  15. (2006). Hypercoagulopathy in stroke patients with nonvalvular atrial fibrillation: hematologic and cardiologic investigations. Clin Appl Thromb Hemost
  16. Interobserver agreement in the classification of stroke in the physicians’ health study.
  17. Plasma measurement of D-dimer levels for early diagnosis of ischemic stroke subtypes.
  18. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly study.